These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33087437)

  • 21. SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens.
    Peng L; Liu J; Xu W; Luo Q; Chen D; Lei Z; Huang Z; Li X; Deng K; Lin B; Gao Z
    J Med Virol; 2020 Sep; 92(9):1676-1680. PubMed ID: 32330305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Repetition of microbiological tests in suspect of SARS-CoV-2 infection: utility of a score based on clinical probability].
    Pardo Lledias J; Ayarza L; González-García P; Salmón González Z; Calvo Montes J; Gozalo Marguello M; Hernández Hernández JL; Olmos Martínez JM
    Rev Esp Quimioter; 2020 Dec; 33(6):410-414. PubMed ID: 32935535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative sensitivity of anterior nares and nasopharyngeal swabs for initial detection of SARS-CoV-2 in ambulatory patients: Rapid review and meta-analysis.
    Zhou Y; O'Leary TJ
    PLoS One; 2021; 16(7):e0254559. PubMed ID: 34283845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strengths and weakness of diagnostic tests of SARS CoV-2 infection.
    Hernández-Pérez JM; Martín-González E; Pino-Yanes M
    Med Clin (Barc); 2020 Nov; 155(10):464-465. PubMed ID: 32546315
    [No Abstract]   [Full Text] [Related]  

  • 25. Performing the nasopharyngeal and oropharyngeal swab for 2019-novel coronavirus (SARS-CoV-2) safely: How to dress, undress, and technical notes.
    Di Maio P; Iocca O; Cavallero A; Giudice M
    Head Neck; 2020 Jul; 42(7):1548-1551. PubMed ID: 32357377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type.
    Lephart PR; Bachman MA; LeBar W; McClellan S; Barron K; Schroeder L; Newton DW
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115200. PubMed ID: 32980807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing SARS-CoV-2 Testing in Anterior Nasal Vestibular Swabs vs. Oropharyngeal Swabs.
    Li M; Wei R; Yang Y; He T; Shen Y; Qi T; Han T; Song Z; Zhu Z; Ma X; Lin Y; Yuan Y; Zhao K; Lu H; Zhou X
    Front Cell Infect Microbiol; 2021; 11():653794. PubMed ID: 34307187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variability in instructions for performance of nasopharyngeal swabs across Canada in the era of COVID-19 - what type of swab is actually being performed?
    Hiebert NM; Chen BA; Sowerby LJ
    J Otolaryngol Head Neck Surg; 2021 Jan; 50(1):5. PubMed ID: 33509292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultra-absorptive Nanofiber Swabs for Improved Collection and Test Sensitivity of SARS-CoV-2 and other Biological Specimens.
    McCarthy A; Saldana L; Ackerman DN; Su Y; John JV; Chen S; Weihs S; Reid SP; Santarpia JL; Carlson MA; Xie J
    Nano Lett; 2021 Feb; 21(3):1508-1516. PubMed ID: 33501831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upper respiratory tract sampling in COVID-19.
    Mawaddah A; Gendeh HS; Lum SG; Marina MB
    Malays J Pathol; 2020 Apr; 42(1):23-35. PubMed ID: 32342928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oropharyngeal Secretion as Alternative for SARS-CoV-2 Detection.
    Yu C; Li L; Tuersun Y; Zhao X; Feng Q; Zhang T; Tay FR; Ma J
    J Dent Res; 2020 Sep; 99(10):1199-1205. PubMed ID: 32613877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimum Naso-oropharyngeal Swab Procedure for COVID-19: Step-by-Step Preparation and Technical Hints.
    Coden E; Russo F; Arosio AD; Castelnuovo P; Karligkiotis A; Volpi L
    Laryngoscope; 2020 Nov; 130(11):2564-2567. PubMed ID: 32716074
    [No Abstract]   [Full Text] [Related]  

  • 33. The accuracy of healthcare worker versus self collected (2-in-1) Oropharyngeal and Bilateral Mid-Turbinate (OPMT) swabs and saliva samples for SARS-CoV-2.
    Tan SY; Tey HL; Lim ETH; Toh ST; Chan YH; Tan PT; Lee SA; Tan CX; Koh GCH; Tan TY; Siau C
    PLoS One; 2020; 15(12):e0244417. PubMed ID: 33326503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 diagnostics: Some reflections on current assays.
    Antonelli G; Stefani S; Pistello M
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115237. PubMed ID: 33130508
    [No Abstract]   [Full Text] [Related]  

  • 35. Saliva-based testing for diagnosis of SARS-CoV-2 infection: A meta-analysis.
    Kivelä JM; Jarva H; Lappalainen M; Kurkela S
    J Med Virol; 2021 Mar; 93(3):1256-1258. PubMed ID: 33079392
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19).
    Ryan DJ; Toomey S; Madden SF; Casey M; Breathnach OS; Morris PG; Grogan L; Branagan P; Costello RW; De Barra E; Hurley K; Gunaratnam C; McElvaney NG; OBrien ME; Sulaiman I; Morgan RK; Hennessy BT
    Thorax; 2021 Jan; 76(1):86-88. PubMed ID: 33097604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. At-home self-collection of saliva, oropharyngeal swabs and dried blood spots for SARS-CoV-2 diagnosis and serology: Post-collection acceptability of specimen collection process and patient confidence in specimens.
    Valentine-Graves M; Hall E; Guest JL; Adam E; Valencia R; Shinn K; Hardee I; Sanchez T; Siegler AJ; Sullivan PS
    PLoS One; 2020; 15(8):e0236775. PubMed ID: 32756585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhale, then exhale: start afresh to diagnose Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by non-invasive face-mask sampling technique.
    Kanaujia R; Biswal M; Angrup A; Ray P
    Clin Microbiol Infect; 2020 Dec; 26(12):1701-1702. PubMed ID: 32629023
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of Upper Respiratory Viral Load Distributions in Asymptomatic and Symptomatic Children Diagnosed with SARS-CoV-2 Infection in Pediatric Hospital Testing Programs.
    Kociolek LK; Muller WJ; Yee R; Dien Bard J; Brown CA; Revell PA; Wardell H; Savage TJ; Jung S; Dominguez S; Parikh BA; Jerris RC; Kehl SC; Campigotto A; Bender JM; Zheng X; Muscat E; Linam M; Abuogi L; Smith C; Graff K; Hernandez-Leyva A; Williams D; Pollock NR
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33093026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of dispersion or aerosol generation and infection transmission with nasopharyngeal and oropharyngeal swabs for detection of COVID-19: a systematic review.
    Agarwal A; Fernando SM; Honarmand K; Bakaa L; Brar S; Granton D; Chaudhuri D; Chetan D; Hu M; Basmaji J; Muttalib F; Rochwerg B; Adhikari NKJ; Lamontagne F; Murthy S; Hui DS; Gomersall CD; Mubareka S; Diaz J; Burns KE; Couban R; Vandvik PO
    BMJ Open; 2021 Mar; 11(3):e040616. PubMed ID: 33737418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.